Total Payments
$744,268
2024 Payments
$123,517
Companies
50
Transactions
2,011
Medicare Patients
2,520
Medicare Billing
$280,921
Payment Breakdown by Category
Other$613,458 (82.4%)
Travel$75,534 (10.1%)
Food & Beverage$44,339 (6.0%)
Consulting$10,938 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $518,465 | 244 | 69.7% |
| Travel and Lodging | $75,534 | 470 | 10.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $65,343 | 22 | 8.8% |
| Food and Beverage | $44,339 | 1,256 | 6.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $29,650 | 8 | 4.0% |
| Consulting Fee | $10,938 | 7 | 1.5% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$744,268
2,007 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $279,087 | 568 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $134,698 | 318 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $85,650 | 131 | $0 (2024) |
| Allergan, Inc. | $84,231 | 260 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $62,710 | 156 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $60,766 | 83 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $11,538 | 75 | $0 (2024) |
| Celgene Corporation | $5,540 | 65 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $4,021 | 7 | $0 (2017) |
| RedHill Biopharma Inc. | $2,312 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123,517 | 273 | Phathom Pharmaceuticals, Inc. ($85,650) |
| 2023 | $69,323 | 207 | E.R. Squibb & Sons, L.L.C. ($33,499) |
| 2022 | $53,416 | 191 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19,158) |
| 2021 | $86,988 | 205 | AbbVie Inc. ($48,479) |
| 2020 | $53,912 | 142 | AbbVie Inc. ($43,169) |
| 2019 | $108,917 | 314 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($46,310) |
| 2018 | $150,092 | 395 | AbbVie, Inc. ($68,345) |
| 2017 | $98,103 | 284 | Allergan Inc. ($42,983) |
All Payment Transactions
2,011 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | Cash or cash equivalent | $53.60 | General |
| Category: Gastroenterology | ||||||
| 12/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: VIROLOGY | ||||||
| 12/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | ABBVIE INC. | CREON (Drug) | Travel and Lodging | In-kind items and services | $402.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,010.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $328.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $40.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $337.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $286.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 499 | 745 | $284,137 | $61,053 |
| 2022 | 21 | 692 | 932 | $400,120 | $78,862 |
| 2021 | 23 | 795 | 833 | $431,474 | $83,846 |
| 2020 | 14 | 534 | 593 | $297,939 | $57,161 |
Total Patients
2,520
Total Services
3,103
Medicare Billing
$280,921
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 51 | $44,164 | $10,905 | 24.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 73 | 73 | $57,032 | $7,889 | 13.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 162 | $17,982 | $6,598 | 36.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 31 | 31 | $20,518 | $6,002 | 29.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 69 | 74 | $48,161 | $5,533 | 11.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 91 | $14,560 | $4,740 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $10,815 | $3,212 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 39 | $12,451 | $3,112 | 25.0% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,103 | $2,757 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 42 | $9,021 | $2,567 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 31 | $5,171 | $1,930 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $6,676 | $1,891 | 28.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $8,972 | $1,886 | 21.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 19 | $5,068 | $1,269 | 25.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $1,905 | $494.28 | 25.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,954 | $149.13 | 1.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 26 | 27 | $584.00 | $120.91 | 20.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 55 | 57 | $47,516 | $12,306 | 25.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 91 | $81,999 | $10,117 | 12.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 102 | $70,233 | $8,540 | 12.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 148 | $21,016 | $6,180 | 29.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 49 | $15,941 | $5,208 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 55 | $21,725 | $4,470 | 20.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 81 | $15,147 | $4,441 | 29.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $12,144 | $4,328 | 35.6% |
About Dr. Venkatachala Mohan, MD
Dr. Venkatachala Mohan, MD is a Gastroenterology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194704106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Venkatachala Mohan, MD has received a total of $744,268 in payments from pharmaceutical and medical device companies, with $123,517 received in 2024. These payments were reported across 2,011 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($518,465).
As a Medicare-enrolled provider, Mohan has provided services to 2,520 Medicare beneficiaries, totaling 3,103 services with total Medicare billing of $280,921. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Bellevue, WA
- Active Since 01/10/2006
- Last Updated 02/20/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1194704106
Products in Payments
- LINZESS (Drug) $114,941
- VOQUEZNA (Drug) $85,650
- CREON (Drug) $80,287
- TRULANCE (Drug) $72,392
- ZEPOSIA (Drug) $64,436
- Trulance (Drug) $62,710
- XIFAXAN (Drug) $55,120
- Creon (Drug) $45,147
- Amitiza (Drug) $10,196
- PLENVU (Drug) $10,177
- ZENPEP (Drug) $6,496
- Movantik (Drug) $2,234
- DUPIXENT (Biological) $2,064
- Alinia Tablets 500mg 30 count bottle (Drug) $1,387
- XELJANZ (Drug) $1,368
- RINVOQ (Biological) $1,140
- ENTYVIO (Biological) $798.32
- STELARA (Biological) $683.47
- IBSRELA (Drug) $607.59
- SKYRIZI (Biological) $603.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bellevue
Shie-Pon Tzung, Md Phd, MD PHD
Gastroenterology — Payments: $39,955
Gastroenterology $39,955
Robert Wohlman, Md, MD
Gastroenterology — Payments: $37,463
Gastroenterology $37,463
Sang Kim, M.d, M.D
Gastroenterology — Payments: $30,884
Gastroenterology $30,884
Raj Butani, M.d, M.D
Gastroenterology — Payments: $12,430
Gastroenterology $12,430
Edwin Lai, M.d, M.D
Gastroenterology — Payments: $11,715
Gastroenterology $11,715
Georgia Rees-Lui, M.d, M.D
Gastroenterology — Payments: $9,998
Gastroenterology $9,998